Logo image of SKIN

BEAUTY HEALTH CO/THE (SKIN) Stock Price, Quote, News and Overview

NASDAQ:SKIN - Nasdaq - US88331L1089 - Common Stock - Currency: USD

1.14  +0.11 (+10.68%)

After market: 1.19 +0.05 (+4.39%)

SKIN Quote, Performance and Key Statistics

BEAUTY HEALTH CO/THE

NASDAQ:SKIN (5/2/2025, 8:23:21 PM)

After market: 1.19 +0.05 (+4.39%)

1.14

+0.11 (+10.68%)

Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products
Statistics
52 Week High3.63
52 Week Low0.78
Market Cap143.63M
Shares125.99M
Float110.47M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-08 2025-05-08/amc
IPO02-10 2020-02-10


SKIN short term performance overview.The bars show the price performance of SKIN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20

SKIN long term performance overview.The bars show the price performance of SKIN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SKIN is 1.14 USD. In the past month the price decreased by -14.29%. In the past year, price decreased by -66.07%.

BEAUTY HEALTH CO/THE / SKIN Daily stock chart

SKIN Competitors/Peers

The largest stocks on the US markets in the "Personal Care Products" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
UL UNILEVER PLC-SPONSORED ADR 23.96 155.96B
KVUE KENVUE INC 21.04 46.01B
EL ESTEE LAUDER COMPANIES-CL A 28.97 21.36B
BRBR BELLRING BRANDS INC 37.94 10.12B
COTY COTY INC-CL A 18.46 4.51B
ELF ELF BEAUTY INC 21.67 3.84B
IPAR INTERPARFUMS INC 21.65 3.63B
ODD ODDITY TECH LTD-CL A 31.16 3.53B
EPC EDGEWELL PERSONAL CARE CO 10.58 1.49B
OLPX OLAPLEX HOLDINGS INC 12.45 912.09M
HLF HERBALIFE LTD 3.55 741.81M
USNA USANA HEALTH SCIENCES INC 11.92 555.24M

About SKIN

Company Profile

SKIN logo image The Beauty Health Co. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. The company is headquartered in Long Beach, California and currently employs 769 full-time employees. The company went IPO on 2020-02-10. The firm and its subsidiaries design, develop, manufacture, market, and sell esthetic technologies and products. The company specializes in skin health for all ages, genders, skin tones, and skin types. Its brands include Hydrafacial, SkinStylus, and Keravive. Hydrafacial created the category of hydradermabrasion with its patented delivery system that cleanses, extracts, and hydrates the skin with proprietary solutions and serums. SkinStylus specializes in nanoneedling and microneedling, where its products are designed to provide either a non-invasive (nanoneedling) or minimally invasive (microneedling) skin treatment to individuals. Keravive specializes in scalp health with its products that are designed to support the hair’s natural growth by cleansing, exfoliating, and hydrating the scalp and hair follicles.

Company Info

BEAUTY HEALTH CO/THE

2165 Spring Street

Long Beach CALIFORNIA 33139 US

CEO: Brenton L. Saunders

Employees: 881

SKIN Company Website

SKIN Investor Relations

Phone: 18006034996

BEAUTY HEALTH CO/THE / SKIN FAQ

What is the stock price of BEAUTY HEALTH CO/THE today?

The current stock price of SKIN is 1.14 USD. The price increased by 10.68% in the last trading session.


What is the ticker symbol for BEAUTY HEALTH CO/THE stock?

The exchange symbol of BEAUTY HEALTH CO/THE is SKIN and it is listed on the Nasdaq exchange.


On which exchange is SKIN stock listed?

SKIN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for BEAUTY HEALTH CO/THE stock?

14 analysts have analysed SKIN and the average price target is 1.61 USD. This implies a price increase of 40.92% is expected in the next year compared to the current price of 1.14. Check the BEAUTY HEALTH CO/THE stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BEAUTY HEALTH CO/THE worth?

BEAUTY HEALTH CO/THE (SKIN) has a market capitalization of 143.63M USD. This makes SKIN a Micro Cap stock.


How many employees does BEAUTY HEALTH CO/THE have?

BEAUTY HEALTH CO/THE (SKIN) currently has 881 employees.


What are the support and resistance levels for BEAUTY HEALTH CO/THE (SKIN) stock?

BEAUTY HEALTH CO/THE (SKIN) has a support level at 1 and a resistance level at 1.33. Check the full technical report for a detailed analysis of SKIN support and resistance levels.


Is BEAUTY HEALTH CO/THE (SKIN) expected to grow?

The Revenue of BEAUTY HEALTH CO/THE (SKIN) is expected to decline by -12.11% in the next year. Check the estimates tab for more information on the SKIN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BEAUTY HEALTH CO/THE (SKIN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BEAUTY HEALTH CO/THE (SKIN) stock pay dividends?

SKIN does not pay a dividend.


When does BEAUTY HEALTH CO/THE (SKIN) report earnings?

BEAUTY HEALTH CO/THE (SKIN) will report earnings on 2025-05-08, after the market close.


What is the Price/Earnings (PE) ratio of BEAUTY HEALTH CO/THE (SKIN)?

BEAUTY HEALTH CO/THE (SKIN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.18).


What is the Short Interest ratio of BEAUTY HEALTH CO/THE (SKIN) stock?

The outstanding short interest for BEAUTY HEALTH CO/THE (SKIN) is 7.09% of its float. Check the ownership tab for more information on the SKIN short interest.


SKIN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SKIN Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SKIN. While SKIN seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SKIN Financial Highlights

Over the last trailing twelve months SKIN reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS decreased by -211.87% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -4.24%
ROE -56.17%
Debt/Equity 10.66
Chartmill High Growth Momentum
EPS Q2Q%-14.29%
Sales Q2Q%-13.74%
EPS 1Y (TTM)-211.87%
Revenue 1Y (TTM)-16.01%

SKIN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 49% to SKIN. The Buy consensus is the average rating of analysts ratings from 14 analysts.

For the next year, analysts expect an EPS growth of -52.43% and a revenue growth -12.11% for SKIN


Ownership
Inst Owners86.75%
Ins Owners8.64%
Short Float %7.09%
Short Ratio11.35
Analysts
Analysts48.57
Price Target1.61 (41.23%)
EPS Next Y-52.43%
Revenue Next Year-12.11%